ArticleBreast cancer research and treatment2022

Ubiquitin-conjugating enzyme 2C (UBE2C) is a poor prognostic biomarker in invasive breast cancer.

Yousif Kariri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.